AKP, page-3

Whether the next ANN comes today, this week or in four weeks' time, I'm very relaxed about my investment here in AKP. I have no doubt we will be in for the mother of all reratings if we can get these working prototypes functioning as our Israeli techies expect we can. I think this stock has one of the best risk reward profiles on offer given where we are in the monetisation lifecycle... The website being down is interesting, but also annoying as I wanted to take another look at the 4C. From memory, I believed the R&D spend had tailed off significantly to around $600k for the quarter, compared to in excess of $1M last quarter. For me this ramp down in R&D spending translates to things going well on the testing and evaluation front...I would have expected spending to be at least the same or even higher then last quarter if we were experiencing troubles. In my many years of investing in techs, this little rule of thumb has served me well...(knock on wood).